Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.51 | 10.07 | 9.55 | 8.75 | 8.07 | 8.83 | 9.17 | 8.65 | 9.47 | 9.11 | 9.81 | 8.59 |
| Expenses | 8.96 | 9.80 | 9.07 | 8.68 | 8.29 | 9.20 | 8.83 | 9.17 | 9.17 | 9.45 | 9.56 | 8.24 |
| Operating Profit | 0.55 | 0.27 | 0.48 | 0.07 | -0.22 | -0.37 | 0.34 | -0.52 | 0.30 | -0.34 | 0.25 | 0.35 |
| OPM % | 5.78% | 2.68% | 5.03% | 0.80% | -2.73% | -4.19% | 3.71% | -6.01% | 3.17% | -3.73% | 2.55% | 4.07% |
| Other Income | 0.04 | 0.15 | 0.18 | 0.08 | 0.08 | 0.26 | 0.42 | 0.27 | 0.34 | 0.27 | 0.24 | 0.11 |
| Interest | 0.23 | 0.23 | 0.24 | 0.24 | 0.23 | 0.23 | 0.22 | 0.22 | 0.23 | 0.22 | 0.23 | 0.22 |
| Depreciation | 0.30 | 0.30 | 0.29 | 0.31 | 0.31 | 0.31 | 0.23 | 0.29 | 0.28 | 0.27 | 0.26 | 0.25 |
| Profit before tax | 0.06 | -0.11 | 0.13 | -0.40 | -0.68 | -0.65 | 0.31 | -0.76 | 0.13 | -0.56 | 0.00 | -0.01 |
| Tax % | 33.33% | -63.64% | 446.15% | -5.00% | -1.47% | -3.08% | 3.23% | -1.32% | -15.38% | -1.79% | -200.00% | |
| Net Profit | 0.04 | -0.04 | -0.44 | -0.38 | -0.67 | -0.63 | 0.31 | -0.74 | 0.15 | -0.54 | -0.02 | 0.00 |
| EPS in Rs | 0.05 | -0.05 | -0.59 | -0.51 | -0.90 | -0.84 | 0.42 | -0.99 | 0.20 | -0.72 | -0.03 | 0.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.36 | 18.79 | 23.11 | 22.00 | 25.33 | 19.15 | 30.86 | 38.19 | 37.38 | 33.76 | 35.90 | 36.98 |
| Expenses | 17.34 | 17.49 | 19.30 | 19.89 | 22.88 | 18.51 | 25.12 | 35.16 | 35.48 | 33.96 | 36.18 | 36.42 |
| Operating Profit | 3.02 | 1.30 | 3.81 | 2.11 | 2.45 | 0.64 | 5.74 | 3.03 | 1.90 | -0.20 | -0.28 | 0.56 |
| OPM % | 14.83% | 6.92% | 16.49% | 9.59% | 9.67% | 3.34% | 18.60% | 7.93% | 5.08% | -0.59% | -0.78% | 1.51% |
| Other Income | 0.14 | 0.13 | 0.22 | 0.50 | 0.73 | 0.52 | 0.39 | 0.32 | 0.28 | 0.85 | 1.12 | 0.96 |
| Interest | 1.34 | 1.36 | 1.39 | 1.36 | 1.39 | 1.14 | 0.98 | 0.89 | 0.92 | 0.91 | 0.90 | 0.90 |
| Depreciation | 1.16 | 1.12 | 1.15 | 1.20 | 1.24 | 1.27 | 1.17 | 1.18 | 1.16 | 1.16 | 1.09 | 1.06 |
| Profit before tax | 0.66 | -1.05 | 1.49 | 0.05 | 0.55 | -1.25 | 3.98 | 1.28 | 0.10 | -1.42 | -1.15 | -0.44 |
| Tax % | 0.00% | 0.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.47% | 530.00% | -3.52% | -2.61% | |
| Net Profit | 0.65 | -1.06 | 1.50 | 0.05 | 0.55 | -1.25 | 3.98 | 0.89 | -0.43 | -1.37 | -1.12 | -0.41 |
| EPS in Rs | 0.87 | -1.42 | 2.01 | 0.07 | 0.74 | -1.67 | 5.33 | 1.19 | -0.58 | -1.83 | -1.50 | -0.55 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 6% | 13% | -2% | 7% | ||
| Compounded Profit Growth | % | 2% | % | 76% | ||
| Stock Price CAGR | 11% | 7% | 11% | -11% | ||
| Return on Equity | % | % | % | % |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Reserves | -12.94 | -12.29 | -13.21 | -11.64 | -11.60 | -11.03 | -12.24 | -8.25 | -7.35 | -7.80 | -9.36 | -10.54 |
| Borrowings | 12.13 | 12.20 | 12.24 | 12.26 | 12.21 | 11.48 | 11.48 | 10.63 | 10.63 | 11.42 | 10.63 | 10.63 |
| Other Liabilities | 12.05 | 11.09 | 11.84 | 11.26 | 11.11 | 11.53 | 12.49 | 11.54 | 11.35 | 11.72 | 13.76 | 13.68 |
| Total Liabilities | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 21.24 |
| Fixed Assets | 15.27 | 14.51 | 14.01 | 14.53 | 14.07 | 13.86 | 12.87 | 14.08 | 13.94 | 14.66 | 13.77 | 12.77 |
| CWIP | 0.01 | 0.07 | 0.02 | 0.02 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.43 | 3.89 | 4.31 | 4.80 | 5.00 | 5.47 | 6.21 | 7.31 | 8.16 | 8.15 | 8.73 | 8.47 |
| Total Assets | 18.71 | 18.47 | 18.34 | 19.35 | 19.19 | 19.45 | 19.20 | 21.39 | 22.10 | 22.81 | 22.50 | 21.24 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 4.00 | 1.74 | 2.61 | 2.20 | 2.31 | 2.99 | 3.30 | 3.97 | 2.95 | 2.09 | 2.17 | 0.37 |
| Cash from Investing Activity | -1.78 | -0.23 | -0.47 | -1.61 | -0.81 | -0.95 | -0.14 | -2.21 | -1.91 | -1.86 | -0.75 | -1.62 |
| Cash from Financing Activity | -2.00 | -1.41 | -1.32 | -1.37 | -1.41 | -2.12 | -0.98 | -1.62 | -0.75 | 0.03 | -1.56 | -0.74 |
| Net Cash Flow | 0.22 | 0.10 | 0.82 | -0.77 | 0.10 | -0.08 | 2.18 | 0.14 | 0.29 | 0.26 | -0.14 | -2.00 |
| Free Cash Flow | 2.45 | 1.28 | 2.05 | 0.56 | 1.44 | 1.95 | 3.02 | 1.68 | 1.87 | 0.03 | 1.90 | 0.27 |
| CFO/OP | 187% | 58% | 201% | 58% | 109% | 122% | 516% | 69% | 97% | 110% | -1,085% | -132% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 10.53 | 9.68 | 11.27 | 12.16 | 13.77 | 15.27 | 15.06 | 10.88 | 11.28 | 6.25 | 8.65 | 9.15 |
| Inventory Days | 32.03 | 46.85 | 46.28 | 50.71 | 40.84 | 39.46 | 45.33 | 20.98 | 22.71 | 21.50 | 24.49 | 20.41 |
| Days Payable | 108.01 | 80.41 | 87.33 | 88.28 | 80.39 | 66.15 | 117.24 | 105.93 | 88.74 | 51.61 | 89.40 | 73.39 |
| Cash Conversion Cycle | -65.45 | -23.88 | -29.79 | -25.40 | -25.78 | -11.42 | -56.85 | -74.08 | -54.75 | -23.85 | -56.26 | -43.83 |
| Working Capital Days | -185.72 | -143.60 | -178.91 | -123.83 | -125.76 | -95.83 | -170.78 | -81.73 | -67.28 | -74.02 | -98.71 | -94.05 |
| ROCE % | 14.36% | 28.49% | 4.47% | 39.48% | 17.44% | 24.25% | -1.50% | 59.90% | 21.36% | 11.08% | -5.14% | -3.07% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 55.78% | 55.78% | 55.78% | 55.78% | 55.78% | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% | 57.10% |
| DIIs | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% | 0.14% |
| Public | 44.08% | 44.08% | 44.09% | 44.09% | 44.09% | 42.75% | 42.75% | 42.75% | 42.75% | 42.77% | 42.76% | 42.76% |
| No. of Shareholders | 8,187 | 8,554 | 8,556 | 8,541 | 8,659 | 8,707 | 8,632 | 8,625 | 8,671 | 8,549 | 8,540 | 8,552 |
Fundamentals
Market Cap₹ 27.8 Cr.
Current Price₹ 37.2
Book Value₹ -4.11
ROCE-3.07 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)7%
Compounded Profit Growth (TTM)76%
Standalone figures.
Valuation
Market capRs 27 Cr
Enterprise valueRs 33 Cr
Price to book-8.91x
Price to sales0.74x
EV / EBITDA40.41x
EV / sales0.89x
Price to cash flow73.90x
Earnings yield-4.10%
P/B, 3-year average-32.19x
P/E, 5-year average9.96x
P/B, 5-year average-0.65x
Profitability
Operating margin (excl. other income)-0.78%
Operating margin (incl. other income)2.34%
EBITDA margin2.19%
Pre-tax margin-3.11%
Net profit margin-3.03%
ROE45.16%
ROCE-3.07%
ROA-5.12%
ROE, 3-year average192.70%
ROCE, 3-year average0.38%
ROA, 3-year average-4.36%
ROE, 5-year average33.00%
ROCE, 5-year average16.42%
ROA, 5-year average2.12%
ROIC (approx.)-10.49%
Tax rate2.61%
Other income / net worth-36.48%
Growth
Sales growth (latest year)6.34%
Sales CAGR, 3 years-2.04%
Sales CAGR, 5 years13.39%
Sales growth QoQ-12.44%
Sales growth YoY (latest quarter)-0.69%
Per share
EPS (TTM)Rs -1.50
EPS (latest year)Rs -1.50
EPS, 3-year averageRs -1.30
EPS, 5-year averageRs 0.52
Book value per shareRs -4.11
Sales per shareRs 49.51
Cash flow per shareRs 0.50
Free cash flow per shareRs 0.36
Efficiency
Asset turnover1.69x
Fixed asset turnover2.81x
Inventory turnover27.19x
Inventory days13 days
Debtor days9 days
Debtors turnover39.89x
Creditor days73 days
Cash conversion cycle-44 days
Working capital days-94 days
Leverage
Total debtRs 11 Cr
Cash and bankRs 5 Cr
Net debtRs 5 Cr
Debt to equity-3.46x
Net debt / EBITDA6.65x
Interest coverage-0.28x
Owners' fund to total sources-14.45%
Debt to assets50.05%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Cash from ops / profit, 5 years5.92x
Sales to cash flow97.03x
Statement figures
Net sales (TTM)Rs 37 Cr
Net sales (latest year)Rs 36 Cr
Sales (latest quarter)Rs 9 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -1 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -1 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 11 Cr
Total expenditure (latest year)Rs 36 Cr
Total income (latest year)Rs 37 Cr
Share capitalRs 7 Cr
ReservesRs -11 Cr
Shareholders' fundsRs -3 Cr
Total assetsRs 21 Cr
Net blockRs 13 Cr
ReceivablesRs 1 Cr
InventoryRs 0 Cr
Other liabilitiesRs 14 Cr
Shares outstanding (crore)0.75
Ownership
Promoter holding57.10% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | 523489 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -4.9% | -2.8% | -2.2 pts |
| 1 month | -3.5% | -6.8% | +3.3 pts |
| 3 months | -5.8% | -7.6% | +1.8 pts |
| 3 years | +26.8% | +14.2% | +12.6 pts |
| 5 years | +25.8% | +27.9% | -2.1 pts |
Red flags
F-score 5 of 8| serious | Negative equity Shareholders' equity is negative |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹9 Cr -0.7% vs Jun 2025.
Net profit ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Chennai Meenakshi Multispeciality Hospital Ltd?
Chennai Meenakshi Multispeciality Hospital Ltd (523489) has a market capitalisation of Rs 27.8 Cr. at the 2026-10-01 close.
What were Chennai Meenakshi Multispeciality Hospital Ltd's latest quarterly results?
In the Jun 2026 quarter, Chennai Meenakshi Multispeciality Hospital Ltd sales was Rs 9 Cr (-0.7% vs Jun 2025) and net profit was Rs 0 Cr.